1.66
Schlusskurs vom Vortag:
$1.63
Offen:
$1.61
24-Stunden-Volumen:
192.85K
Relative Volume:
0.38
Marktkapitalisierung:
$8.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-2.253
EPS:
-0.7368
Netto-Cashflow:
-
1W Leistung:
+3.75%
1M Leistung:
+2.47%
6M Leistung:
-68.12%
1J Leistung:
-86.72%
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Vergleichen Sie CLDI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CLDI
Calidi Biotherapeutics Inc
|
1.66 | 8.72M | 0 | -23.36M | 0 | -0.7368 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-11-22 | Eingeleitet | H.C. Wainwright | Buy |
2023-10-09 | Eingeleitet | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
Can Calidi Biotherapeutics Inc. stock beat market expectations this quarterWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
Can a trend reversal in Calidi Biotherapeutics Inc. lead to recoveryTrade Exit Summary & Weekly Breakout Watchlists - newser.com
Is Calidi Biotherapeutics Inc. stock supported by strong cash flowsWeekly Gains Summary & Short-Term Swing Trade Alerts - newser.com
Will Calidi Biotherapeutics Inc. stock keep outperforming rivalsWeekly Loss Report & Weekly High Return Forecasts - newser.com
Will Calidi Biotherapeutics Inc. rebound enough to break evenTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com
Full technical analysis of Calidi Biotherapeutics Inc. stockJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Is Calidi Biotherapeutics Inc. forming a reversal patternPortfolio Update Report & Expert Approved Momentum Trade Ideas - newser.com
Can Calidi Biotherapeutics Inc. stock rebound after recent weaknessPortfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
How to manage a losing position in Calidi Biotherapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
News impact scoring models applied to Calidi Biotherapeutics Inc.Quarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
How institutional ownership impacts Calidi Biotherapeutics Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com
Is Calidi Biotherapeutics Inc. stock bottoming outJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
What’s the recovery path for long term holders of Calidi Biotherapeutics Inc.2025 Key Highlights & AI Enhanced Trading Signals - newser.com
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pueblo Chieftain
How Calidi Biotherapeutics Inc. stock reacts to monetary easingGold Moves & Weekly Chart Analysis and Guides - newser.com
Applying big data sentiment scoring on Calidi Biotherapeutics Inc.2025 Price Targets & Weekly High Return Opportunities - newser.com
Can technical indicators confirm Calidi Biotherapeutics Inc.’s reversalPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Published on: 2025-10-10 04:53:50 - newser.com
How rising interest rates impact Calidi Biotherapeutics Inc. stockTrade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Will Calidi Biotherapeutics Inc. stock maintain growth storyQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-09 06:45:08 - newser.com
Will Calidi Biotherapeutics Inc. stock justify high valuationMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Analyzing Calidi Biotherapeutics Inc. with risk reward ratio chartsJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
Why ETFs are accumulating Calidi Biotherapeutics Inc. stockIPO Watch & Low Drawdown Investment Strategies - newser.com
Will Calidi Biotherapeutics Inc. continue its uptrendWeekly Market Report & Low Risk Entry Point Guides - newser.com
Is it time to cut losses on Calidi Biotherapeutics Inc.Take Profit & Precise Swing Trade Entry Alerts - newser.com
Visual analytics tools that track Calidi Biotherapeutics Inc. performanceQuarterly Market Review & Community Consensus Trade Signals - newser.com
Using Ichimoku Cloud for Calidi Biotherapeutics Inc. technicalsAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Calidi Biotherapeutics Inc-Aktie (CLDI) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Poma Eric E | Chief Executive Officer |
Aug 21 '25 |
Buy |
2.00 |
25,000 |
50,000 |
25,000 |
Leftwich Scott | Director |
Aug 21 '25 |
Buy |
2.00 |
125,000 |
250,000 |
130,650 |
Jackson Andrew C. | Chief Financial Officer |
Aug 21 '25 |
Buy |
2.00 |
2,500 |
5,000 |
2,500 |
Camaisa Allan | CEO and Chairman of the Board |
Dec 17 '24 |
Sale |
1.62 |
10,000 |
16,200 |
66,712 |
Kapitalisierung:
|
Volumen (24h):